HomeComparePCELF vs MRK

PCELF vs MRK: Dividend Comparison 2026

PCELF yields 107.24% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PCELF wins by $5.16M in total portfolio value
10 years
PCELF
PCELF
● Live price
107.24%
Share price
$1.87
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.21M
Annual income
$1,839,813.53
Full PCELF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PCELF vs MRK

📍 PCELF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPCELFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PCELF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PCELF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCELF
Annual income on $10K today (after 15% tax)
$9,115.28/yr
After 10yr DRIP, annual income (after tax)
$1,563,841.50/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, PCELF beats the other by $1,555,513.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCELF + MRK for your $10,000?

PCELF: 50%MRK: 50%
100% MRK50/50100% PCELF
Portfolio after 10yr
$2.64M
Annual income
$924,805.84/yr
Blended yield
35.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PCELF
No analyst data
Altman Z
2.9
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCELF buys
0
MRK buys
0
No recent congressional trades found for PCELF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPCELFMRK
Forward yield107.24%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$5.21M$56.8K
Annual income after 10y$1,839,813.53$9,798.13
Total dividends collected$4.69M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PCELF vs MRK ($10,000, DRIP)

YearPCELF PortfolioPCELF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$21,424$10,723.86$11,206$366.19+$10.2KPCELF
2$44,395$21,471.63$12,650$502.35+$31.7KPCELF
3$89,086$41,583.33$14,407$694.19+$74.7KPCELF
4$173,307$77,984.82$16,585$967.82+$156.7KPCELF
5$327,224$141,785.62$19,342$1,363.89+$307.9KPCELF
6$600,324$250,194.39$22,913$1,947.19+$577.4KPCELF
7$1,071,324$428,977.33$27,662$2,823.89+$1.04MPCELF
8$1,861,777$715,460.46$34,159$4,173.35+$1.83MPCELF
9$3,154,109$1,162,006.85$43,337$6,308.80+$3.11MPCELF
10$5,214,710$1,839,813.53$56,776$9,798.13+$5.16MPCELF

PCELF vs MRK: Complete Analysis 2026

PCELFStock

PowerCell Sweden AB (publ) develops and produces fuel cells and fuel cell systems for automotive, marine, and stationary applications in Sweden and internationally. It offers PowerCell S2 based solutions that comprise PowerCell MS-30, a fuel cell system for battery-operated electric vehicles; PowerCell PS-5, a fuel cell system that is used for electricity generation, as well as an auxiliary power generator for telecom, traffic, building, and household applications; and PowerCell S2 fuel cell stack. The company also offers PowerCell S3 based solutions, including Powercell MS-100 for heavy-duty use applications; PowerCell megawatt solutions for marine and stationary applications; and PowerCell S3 fuel cell stack for stationary and mobile applications. In addition, it offers engineering services and zero emission solutions. The company was founded in 2008 and is based in Gothenburg, Sweden.

Full PCELF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PCELF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCELF vs SCHDPCELF vs JEPIPCELF vs OPCELF vs KOPCELF vs MAINPCELF vs JNJPCELF vs ABBVPCELF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.